Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.

NCT04515290 is registered in ClinicalTrials.gov with Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd. as lead sponsor.

NCT NCT04515290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04515290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IIa Clinical Trial on TSG-01 in the Treatment of Chronic Heart Failure in Patients With Coronary Heart Disease.
Lead sponsor
Shanghai Hongyitang Biopharmaceutical Technology Co. Ltd.
Phase
Phase 2
Overall status
Completed
Start date
May 7, 2020
Completion date
April 22, 2022
Enrollment
85 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic heart failure